Don't be daft.  I never said my friends worked for stem cell therapeutics...that would be a dumb thing to say even if it could be true.  Right now they are running very lean it would seem from the letters that have been put out.  A good strategy indeed and to be attracting attention from anyone other than bottom feeding IP raiders at this point is certainly impressive.

That area is teeming with people who are clinical researchers, strategists, IP experts, MDs PhDs....

The cafes are full of individuals who have insightful perspectives on yours, and many other companies.